Cargando…

Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan

Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hosp...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhai, Heng, Lv, Yinzhang, Xu, Yu, Wu, Yi, Zeng, Weiqi, Wang, Tao, Cao, Xuebing, Xu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Vienna 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779096/
https://www.ncbi.nlm.nih.gov/pubmed/33392827
http://dx.doi.org/10.1007/s00702-020-02283-y
_version_ 1783631263447384064
author Zhai, Heng
Lv, Yinzhang
Xu, Yu
Wu, Yi
Zeng, Weiqi
Wang, Tao
Cao, Xuebing
Xu, Yan
author_facet Zhai, Heng
Lv, Yinzhang
Xu, Yu
Wu, Yi
Zeng, Weiqi
Wang, Tao
Cao, Xuebing
Xu, Yan
author_sort Zhai, Heng
collection PubMed
description Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 (p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-020-02283-y.
format Online
Article
Text
id pubmed-7779096
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Vienna
record_format MEDLINE/PubMed
spelling pubmed-77790962021-01-04 Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan Zhai, Heng Lv, Yinzhang Xu, Yu Wu, Yi Zeng, Weiqi Wang, Tao Cao, Xuebing Xu, Yan J Neural Transm (Vienna) Neurology and Preclinical Neurological Studies - Original Article Information about Parkinson’s disease (PD) patients with severe COVID-19 is scarce. We aimed to analyze the clinical characteristics, outcomes, and risk factors affecting the prognosis of PD patients with severe COVID-19 infection. Clinical data of severe COVID-19 patients admitted at the Union Hospital, Wuhan between 28th January and 29th February 2020 were collected and analyzed. 10 patients (1.96%) had a medical history of PD with a mean (SD) age of 72.10 (± 11.46) years. The clinical characteristics and outcomes of severe COVID-19 with and without PD patients were then compared. There was no significant difference in overall mortality between the PD and non-PD patients with severe COVID-19 (p > 0.05). In PD patients with severe COVID-19, the proportion of patients with critical type, disturbance of consciousness, incidence of complications, white blood cells count and neutrophils counts on admission seem higher in the non-survivors. PD patients with older age, longer PD duration, and late stage PD may be highly susceptible to critical COVID-19 infection and bad outcome. The PD patients with consciousness disorders and complications that progressed rapidly are at increased risk of death. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00702-020-02283-y. Springer Vienna 2021-01-03 2021 /pmc/articles/PMC7779096/ /pubmed/33392827 http://dx.doi.org/10.1007/s00702-020-02283-y Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Neurology and Preclinical Neurological Studies - Original Article
Zhai, Heng
Lv, Yinzhang
Xu, Yu
Wu, Yi
Zeng, Weiqi
Wang, Tao
Cao, Xuebing
Xu, Yan
Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
title Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
title_full Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
title_fullStr Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
title_full_unstemmed Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
title_short Characteristic of Parkinson’s disease with severe COVID-19: a study of 10 cases from Wuhan
title_sort characteristic of parkinson’s disease with severe covid-19: a study of 10 cases from wuhan
topic Neurology and Preclinical Neurological Studies - Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7779096/
https://www.ncbi.nlm.nih.gov/pubmed/33392827
http://dx.doi.org/10.1007/s00702-020-02283-y
work_keys_str_mv AT zhaiheng characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT lvyinzhang characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT xuyu characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT wuyi characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT zengweiqi characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT wangtao characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT caoxuebing characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan
AT xuyan characteristicofparkinsonsdiseasewithseverecovid19astudyof10casesfromwuhan